Introduction: Dipeptidyl peptidase-4 inhibitors (DPP4is) are widely used oral antidiabetic agents in type 2 diabetes mellitus (T2DM) (1). They act by enhancing endogenous incretin activity, which promotes glucose-dependent insulin secretion and suppresses glucagon release (1). DPP4is demonstrate modest HbA1c (glycated haemoglobin) reduction of abou
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Pancytopenia, a rare presentation of hyperthyroidism
830 Reached2 Comments
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
Complicated case of Osteoarthritis
1850 Reached2 Comments3 Likes